Dr. Armine Smith discusses advances in prostate cancer surgery and her use of the latest, least invasive, surgical options for appropriate patients.
I am are mean smith. I'm assistant professor of neurology at johns Hopkins University. I'm the director of urologic oncology at Sibley Memorial Hospital. I'm a co director for prostate multidisciplinary clinic at Sibley Memorial. And also I am a co director of bladder cancer women's program, robotic prostatectomy has become a standard of surgical care for prostate cancer. Um It is beneficial in the sense that it allows for less blood loss, less scarring at the juncture of the prostate and urethra or the anastomosis. And any patient who is a candidate for a minimally invasive surgery as a candidate for the robotic press, detective spacer or hydrogel insertion is used widely for patients who are to undergo radiation to the prostate or the proton treatment for the prostate cancer. What it does it separates the prostate from the anterior surface of the rectum and minimizes the risk of damage by the X ray, um and the proton rays to the rectum, hence minimizing the gi side effects of this treatment. Some patients who have failed prostate cancer treatments such as radiation or proton therapy, require therapy. Maybe um candidates for salvage prostatectomy, remove the prostate and sometimes the lymph nodes around the prostate. It can be done robotically or minimally invasively and with a careful consideration and a patient selection, the outcomes are good. The prostate cancer Multidisciplinary clinics bring the specialists from johns Hopkins to interview the patients, sit down together, review the history, come up with the treatments, which are standard of care and also clinical trials that suit the best for the patient. When a referring physician sends a patient to me, they can expect a direct communication back and forth here, the form of the letter or emails or direct phone calls, depending on the preference.